Stuttgart - Delayed Quote EUR

Corcept Therapeutics Inc (HTD.SG)

62.88
+1.56
+(2.54%)
At close: June 10 at 9:41:33 PM GMT+2
Loading Chart for HTD.SG
  • Previous Close 61.32
  • Open 61.16
  • Bid 62.82 x 200000
  • Ask 63.14 x 200000
  • Day's Range 61.16 - 64.18
  • 52 Week Range 25.89 - 106.00
  • Volume 170
  • Avg. Volume 27
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 28, 2025 - Aug 1, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: HTD.SG

View More

Performance Overview: HTD.SG

Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HTD.SG
26.62%
S&P 500 (^GSPC)
2.67%

1-Year Return

HTD.SG
115.56%
S&P 500 (^GSPC)
12.65%

3-Year Return

HTD.SG
212.68%
S&P 500 (^GSPC)
54.81%

5-Year Return

HTD.SG
380.00%
S&P 500 (^GSPC)
89.30%

Compare To: HTD.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HTD.SG

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    6.56B

  • Enterprise Value

    6.28B

  • Trailing P/E

    60.82

  • Forward P/E

    54.64

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    11.83

  • Price/Book (mrq)

    10.86

  • Enterprise Value/Revenue

    10.46

  • Enterprise Value/EBITDA

    63.72

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: HTD.SG

View More

Company Insights: HTD.SG

Research Reports: HTD.SG

View More